SCHEMBL3135791

SCHEMBL3135791

Cc1cc(C)c2cc(Oc3c(Br)cc(C=CC(=O)O)cc3Br)ccc2n1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.43
ALDH1A1 P00352 2/20 0.43
HPGD P15428 2/20 0.43
HSD17B10 Q99714 2/20 0.43
POLB P06746 1/20 0.43
CYP1A2 P05177 1/20 0.40
TSHR P16473 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
GAA P10253 1/20 0.40
ESR1 P03372 9/20 0.40
THRB P10828 2/20 0.39
THRA P10827 1/20 0.39
ESR2 Q92731 4/20 0.38
ATM Q13315 2/20 0.37
IP6K1 Q92551 1/20 0.37
IP6K3 Q96PC2 1/20 0.37
IP6K2 Q9UHH9 1/20 0.37
RHOA P61586 1/20 0.36
EPRS1 P07814 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3135783 1.00 KDM4E (0.43) KDM4EALDH1A1HPGDHSD17B10POLB
SCHEMBL3138737 0.86 MCHR1 (0.42) ESR1ESR2
SCHEMBL3138746 0.86 MCHR1 (0.42) ESR1ESR2
SCHEMBL3142092 0.79 KDM4E (0.46) KDM4EALDH1A1HPGDHSD17B10POLB
SCHEMBL5074377 0.78 CYP1A2 (0.46) KDM4EALDH1A1HPGDHSD17B10POLB
SCHEMBL3140997 0.78 THRA (0.55) KDM4EALDH1A1HPGDHSD17B10POLB
SCHEMBL4295204 0.73 KDM4E (0.44) KDM4EALDH1A1HPGDHSD17B10POLB
SCHEMBL4295197 0.73 KDM4E (0.44) KDM4EALDH1A1HPGDHSD17B10POLB
SCHEMBL3130645 0.73 KDM4E (0.46) KDM4EALDH1A1HPGDHSD17B10GAA
SCHEMBL3130655 0.73 KDM4E (0.46) KDM4EALDH1A1HPGDHSD17B10GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100004271-A1 HETEROCYCLIC COMPOUNDS AS AGANIST FOR THE THYROID RECEPTOR KARO BIO AB (SE) 2010-01-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100004271-A1 HETEROCYCLIC COMPOUNDS AS AGANIST FOR THE THYROID RECEPTOR TSHR, GHSR, TRHR KDM4E 1562/4885ALDH1A1 1081/4885HPGD 1390/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.